Cargando…

Secondary myeloid neoplasias: an emerging group of diseases

Detalles Bibliográficos
Autor principal:	Hernández-Rivas, Jesús M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459381/ https://www.ncbi.nlm.nih.gov/pubmed/23049352 http://dx.doi.org/10.5581/1516-8484.20110111

Ejemplares similares

Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015)

Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies()
por: da Silva, Fernanda Borges, et al.
Publicado: (2015)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

Blood group polymorphisms in Brazil()
por: Castilho, Lilian
Publicado: (2016)

Allergic rhinitis and association with the O blood group
por: Carpeggiani, Clara
Publicado: (2011)

Genetic diversity of the human blood group systems
por: de Mattos, Luiz Carlos
Publicado: (2013)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Molecular polymorphisms of human blood groups: a universe to unravel
por: de Mattos, Luiz Carlos
Publicado: (2011)

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?()
por: Santos, Magnun Nueldo Nunes dos
Publicado: (2015)

Titers of ABO antibodies in group O blood donors: patient safety and blood product supply remain a challenge
por: Denomme, Gregory
Publicado: (2011)

Sickle cell disease: from the beginning until it was recognized as a public health disease
por: Naoum, Paulo Cesar
Publicado: (2011)

Sexuality and sickle cell disease
por: Figueiredo, Maria Stella
Publicado: (2013)

Is sickle cell disease the same everywhere?
por: Hankins, Jane
Publicado: (2012)

Oxidative stress in sickle cell disease
por: Queiroz, Raphael Ferreira, et al.
Publicado: (2013)

Kidd system antigens and kidney disease()
por: Barros, Melca Maria Oliveira
Publicado: (2017)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Comments on renal abnormalities of sickle cell disease
por: Abbud-Filho, Mario
Publicado: (2013)

Oral features of graft-versus-host disease
por: Regina Torres, Sandra
Publicado: (2014)

Stressed ends: telomere attrition in chronic diseases()
por: Fok, Wilson Chun, et al.
Publicado: (2017)

The Langerhans cell histiocytosis: a disease in search of an identity
por: Rodriguez-Galindo, Carlos
Publicado: (2011)

Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Kazmi, Rashid S., et al.
Publicado: (2012)

Sickle cell disease: looking back but towards the future
por: Cançado, Rodolfo Delfini
Publicado: (2012)

Comment on sickle cell disease and left ventricular hypertrophy()
por: Verissimo, Monica Pinheiro de Almeida
Publicado: (2015)

Animal models of human nutritional diseases: a short overview
por: de Vasconcelos, Carlos Augusto Carvalho
Publicado: (2012)

Dynamics of sickle cell disease as one of the determinants of quality of life
por: Ivo, Maria Lúcia, et al.
Publicado: (2013)

The interpretation of rare or novel variants: damaging vs. disease-causing()
por: Gutierrez-Rodrigues, Fernanda, et al.
Publicado: (2018)

Comprehensive healthcare for individuals with sickle cell disease - a constant challenge
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Pregnancy in sickle cell disease – do we know what to expect?()
por: Fertrin, Kleber Yotsumoto
Publicado: (2014)

The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão()
por: Viana, Marcos Borato
Publicado: (2015)

Comment on: “Oral health-related quality of life in children and teens with sickle cell disease”()
por: Correa, Maria Elvira Pizzigatti
Publicado: (2016)

Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease()
por: Piva, Elisa
Publicado: (2015)

Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients
por: Nance, Sandra Taddie, et al.
Publicado: (2013)

Quality of life in sickle cell disease: assessments by the 36-item Short Form Health Survey Questionnaire and Beck Depression Inventory
por: Ivo, Maria Lucia, et al.
Publicado: (2012)

Comment on: Blood discard rate and the prevalence of infectious and contagious diseases in blood donors from provincial towns of the state of Paraná, Brazil
por: Venturini, Danielle
Publicado: (2013)

Qualitative polymerase chain reaction versus quantitative polymerase chain reaction for the detection of minimal residual disease in children with acute lymphoblastic leukemia()
por: Scrideli, Carlos Alberto, et al.
Publicado: (2015)

Comments on Brazilian workshop model for training investigators in chronic graft-versus-host disease according to the 2005-2006 National Institutes of Health recommendations
por: Lee, Stephanie
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2v4u4rjipbtht8om97boq7c9dg